Genetic alteration of the hepatitis C virus hypervariable region obtained from an asymptomatic carrier

T. Nakazawa, Nobuyuki Kato, Y. Ootsuyama, H. Sekiya, T. Fujioka, A. Shibuya, K. Shimotohno

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

Hepatitis C virus (HCV) genome shows extensive sequence diversity at 2 hypervariable regions (HVR1 and HVR2) of the putative envelope glycoprotein (gp70). We recently reported that the amino-acid sequence of HVR1, but not of HVR2, underwent a striking mutation or mutated sequentially over a period of several months in patients with chronic hepatitis (CH). Here, we examined whether these genetic alterations in HVR1 occurred in an asymptomatic HCV carrier. The level of HCV RNA in serum was almost the same throughout the 4 time points sampled over 16 months. However, we found that the amino-acid sequence of the HCV HVR1 from this asymptomatic carrier altered with time, as seen in patients with CH. Alterations of amino acids in the HVRI were correlated with persistent HCV infection rather than with clinical symptoms. Sequence heterogeneity of HVR1 was not correlated with alanine aminotransferase (ALT) values or liver histological findings. The necessity of clinical follow-up of HCV asymptomatic carriers is discussed.

Original languageEnglish
Pages (from-to)204-207
Number of pages4
JournalInternational Journal of Cancer
Volume56
Issue number2
Publication statusPublished - 1994
Externally publishedYes

Fingerprint

Hepacivirus
Chronic Hepatitis
Amino Acid Sequence
Virus Diseases
Alanine Transaminase
Glycoproteins
Genome
RNA
Amino Acids
Mutation
Liver
Serum

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Nakazawa, T., Kato, N., Ootsuyama, Y., Sekiya, H., Fujioka, T., Shibuya, A., & Shimotohno, K. (1994). Genetic alteration of the hepatitis C virus hypervariable region obtained from an asymptomatic carrier. International Journal of Cancer, 56(2), 204-207.

Genetic alteration of the hepatitis C virus hypervariable region obtained from an asymptomatic carrier. / Nakazawa, T.; Kato, Nobuyuki; Ootsuyama, Y.; Sekiya, H.; Fujioka, T.; Shibuya, A.; Shimotohno, K.

In: International Journal of Cancer, Vol. 56, No. 2, 1994, p. 204-207.

Research output: Contribution to journalArticle

Nakazawa, T, Kato, N, Ootsuyama, Y, Sekiya, H, Fujioka, T, Shibuya, A & Shimotohno, K 1994, 'Genetic alteration of the hepatitis C virus hypervariable region obtained from an asymptomatic carrier', International Journal of Cancer, vol. 56, no. 2, pp. 204-207.
Nakazawa, T. ; Kato, Nobuyuki ; Ootsuyama, Y. ; Sekiya, H. ; Fujioka, T. ; Shibuya, A. ; Shimotohno, K. / Genetic alteration of the hepatitis C virus hypervariable region obtained from an asymptomatic carrier. In: International Journal of Cancer. 1994 ; Vol. 56, No. 2. pp. 204-207.
@article{d88893e12f604249a8ccaaa86829049a,
title = "Genetic alteration of the hepatitis C virus hypervariable region obtained from an asymptomatic carrier",
abstract = "Hepatitis C virus (HCV) genome shows extensive sequence diversity at 2 hypervariable regions (HVR1 and HVR2) of the putative envelope glycoprotein (gp70). We recently reported that the amino-acid sequence of HVR1, but not of HVR2, underwent a striking mutation or mutated sequentially over a period of several months in patients with chronic hepatitis (CH). Here, we examined whether these genetic alterations in HVR1 occurred in an asymptomatic HCV carrier. The level of HCV RNA in serum was almost the same throughout the 4 time points sampled over 16 months. However, we found that the amino-acid sequence of the HCV HVR1 from this asymptomatic carrier altered with time, as seen in patients with CH. Alterations of amino acids in the HVRI were correlated with persistent HCV infection rather than with clinical symptoms. Sequence heterogeneity of HVR1 was not correlated with alanine aminotransferase (ALT) values or liver histological findings. The necessity of clinical follow-up of HCV asymptomatic carriers is discussed.",
author = "T. Nakazawa and Nobuyuki Kato and Y. Ootsuyama and H. Sekiya and T. Fujioka and A. Shibuya and K. Shimotohno",
year = "1994",
language = "English",
volume = "56",
pages = "204--207",
journal = "International Journal of Cancer",
issn = "0020-7136",
publisher = "Wiley-Liss Inc.",
number = "2",

}

TY - JOUR

T1 - Genetic alteration of the hepatitis C virus hypervariable region obtained from an asymptomatic carrier

AU - Nakazawa, T.

AU - Kato, Nobuyuki

AU - Ootsuyama, Y.

AU - Sekiya, H.

AU - Fujioka, T.

AU - Shibuya, A.

AU - Shimotohno, K.

PY - 1994

Y1 - 1994

N2 - Hepatitis C virus (HCV) genome shows extensive sequence diversity at 2 hypervariable regions (HVR1 and HVR2) of the putative envelope glycoprotein (gp70). We recently reported that the amino-acid sequence of HVR1, but not of HVR2, underwent a striking mutation or mutated sequentially over a period of several months in patients with chronic hepatitis (CH). Here, we examined whether these genetic alterations in HVR1 occurred in an asymptomatic HCV carrier. The level of HCV RNA in serum was almost the same throughout the 4 time points sampled over 16 months. However, we found that the amino-acid sequence of the HCV HVR1 from this asymptomatic carrier altered with time, as seen in patients with CH. Alterations of amino acids in the HVRI were correlated with persistent HCV infection rather than with clinical symptoms. Sequence heterogeneity of HVR1 was not correlated with alanine aminotransferase (ALT) values or liver histological findings. The necessity of clinical follow-up of HCV asymptomatic carriers is discussed.

AB - Hepatitis C virus (HCV) genome shows extensive sequence diversity at 2 hypervariable regions (HVR1 and HVR2) of the putative envelope glycoprotein (gp70). We recently reported that the amino-acid sequence of HVR1, but not of HVR2, underwent a striking mutation or mutated sequentially over a period of several months in patients with chronic hepatitis (CH). Here, we examined whether these genetic alterations in HVR1 occurred in an asymptomatic HCV carrier. The level of HCV RNA in serum was almost the same throughout the 4 time points sampled over 16 months. However, we found that the amino-acid sequence of the HCV HVR1 from this asymptomatic carrier altered with time, as seen in patients with CH. Alterations of amino acids in the HVRI were correlated with persistent HCV infection rather than with clinical symptoms. Sequence heterogeneity of HVR1 was not correlated with alanine aminotransferase (ALT) values or liver histological findings. The necessity of clinical follow-up of HCV asymptomatic carriers is discussed.

UR - http://www.scopus.com/inward/record.url?scp=0028230023&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028230023&partnerID=8YFLogxK

M3 - Article

VL - 56

SP - 204

EP - 207

JO - International Journal of Cancer

JF - International Journal of Cancer

SN - 0020-7136

IS - 2

ER -